WO2004045380A3 - Compositions containing an active fraction isolated from tannins and methods of use - Google Patents
Compositions containing an active fraction isolated from tannins and methods of use Download PDFInfo
- Publication number
- WO2004045380A3 WO2004045380A3 PCT/US2003/036708 US0336708W WO2004045380A3 WO 2004045380 A3 WO2004045380 A3 WO 2004045380A3 US 0336708 W US0336708 W US 0336708W WO 2004045380 A3 WO2004045380 A3 WO 2004045380A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tannins
- methods
- compositions containing
- active fraction
- fraction isolated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003291015A AU2003291015A1 (en) | 2002-11-15 | 2003-11-17 | Compositions containing an active fraction isolated from tannins and methods of use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42636302P | 2002-11-15 | 2002-11-15 | |
US60/426,363 | 2002-11-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004045380A2 WO2004045380A2 (en) | 2004-06-03 |
WO2004045380A3 true WO2004045380A3 (en) | 2004-07-15 |
Family
ID=32326339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/036708 WO2004045380A2 (en) | 2002-11-15 | 2003-11-17 | Compositions containing an active fraction isolated from tannins and methods of use |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003291015A1 (en) |
TW (1) | TW200423954A (en) |
WO (1) | WO2004045380A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2669918C (en) | 2006-11-15 | 2020-03-10 | Arthritis Relief Plus Ltd | Topical formulation comprising comfrey and tannic acid, and uses thereof |
US8748177B2 (en) * | 2008-09-30 | 2014-06-10 | The Hospital For Sick Children | Compositions for proliferation of cells and related methods |
TWI407953B (en) * | 2011-03-24 | 2013-09-11 | Univ Kaohsiung Medical | Pharmaceutical composition for modulating complement factor b (cfb) expression |
RU2634253C1 (en) * | 2016-12-22 | 2017-10-24 | Федеральное государственное бюджетное учреждение "Российский онкологический научный центр имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "РОНЦ им. Н.Н. Блохина" Минздрава России) | Antiangiogenic drug |
CN113813270B (en) * | 2021-01-21 | 2023-07-21 | 广东盛普生命科技有限公司 | Medicine for preventing and/or treating skin fibrosis |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646136A (en) * | 1994-01-04 | 1997-07-08 | Duke University | Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
-
2003
- 2003-11-17 TW TW92132358A patent/TW200423954A/en unknown
- 2003-11-17 WO PCT/US2003/036708 patent/WO2004045380A2/en not_active Application Discontinuation
- 2003-11-17 AU AU2003291015A patent/AU2003291015A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646136A (en) * | 1994-01-04 | 1997-07-08 | Duke University | Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
Also Published As
Publication number | Publication date |
---|---|
TW200423954A (en) | 2004-11-16 |
WO2004045380A2 (en) | 2004-06-03 |
AU2003291015A1 (en) | 2004-06-15 |
AU2003291015A8 (en) | 2004-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1933833B8 (en) | Therapy for the treatment of overactive bladder | |
WO2007149548A3 (en) | Treatment of erectile dysfunction by stem cell therapy | |
WO2002047673A3 (en) | Methods and compositions to treat conditions associated with neovascularization | |
WO2005091991A3 (en) | Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders | |
WO2008054544A3 (en) | Method for delivery across the blood brain barrier | |
WO2007089584A3 (en) | Compositions and their uses directed to huntingtin | |
WO2006018182A8 (en) | Combinations for the treatment of diseases involving cell proliferation | |
NO20073959L (en) | Quinazoline derivative, method of preparation and use thereof for inhibiting cancer cell growth | |
WO2005076979A3 (en) | Diagnosis and therapeutics for cancer | |
TW200833341A (en) | 6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions | |
UA94097C2 (en) | Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors | |
WO2005117954A3 (en) | Compositions and methods for treatment of neovascular diseases | |
WO2005116002A3 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
MX2010002392A (en) | Improved brimonidine compositions for treating erythema. | |
MXPA06000302A (en) | Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them. | |
NO990433L (en) | New compounds and compositions for the treatment of diseases associated with tryptase activity | |
AU4258101A (en) | Combination therapies with vascular damaging activity | |
BR112012016128A2 (en) | therapeutic agent (y-39983) for corneal endothelial dysfunction | |
WO2005009394A3 (en) | Drug delivery in the nervous system | |
WO2006116185A3 (en) | Methods for the treatment of multiple myeloma | |
WO2004045380A3 (en) | Compositions containing an active fraction isolated from tannins and methods of use | |
EP1152002A4 (en) | Pyrrole derivatives and cell death inhibitors | |
WO2007055760A3 (en) | Protein composition for promoting wound healing and skin regeneration | |
WO2004012677A3 (en) | Methods and compositions to treat conditions associated with neovascularization | |
WO2004043346A3 (en) | Compositions containing an active fraction isolated from lycium barbarum and methods of using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |